---

Short Stature — A Comprehensive Overview

Definition

• Height <2 SD below mid-parental height, OR
• Height velocity <10th percentile for age resulting in downward crossing of height percentiles

---

Mid-Parental Height Calculation

• Boys: [Father's height + (Mother's height + 13 cm)] ÷ 2
• Girls: [(Father's height − 13 cm) + Mother's height] ÷ 2

---

Classification of Causes

1. Non-Pathologic (Most Common)

A. Familial Short Stature (Most Common Overall)

• Parents or close relatives are short
• Normal birth weight and length, growth rate declines in first 2–3 years then parallels but falls below 5th percentile
• Bone age = chronologic age (normal)
• Growth velocity: normal
• Puberty at normal age
• Adult height is short, near mid-parental height
• FDA-approved recombinant GH for idiopathic short stature can increase predicted height by >7 cm

B. Constitutional Growth Delay (2nd Most Common)

• Majority are boys with normal birth length/weight
• Growth decelerates in first 2 years, then returns to normal velocity but at a lower percentile
• Bone age = height age (both delayed relative to chronologic age)
• Delayed puberty — later than peers
• Family history of delayed growth and puberty common
• Adult height is ultimately normal
• Differentiated from familial short stature by bone age: delayed in constitutional delay, normal in familial short stature

---

2. Pathologic Causes

A. Endocrine Disorders

• ~15% of children evaluated for growth retardation have an endocrine disorder; ~half of those (~8% of all short stature) have GHD
• Characteristics: short stature, low growth velocity, immature facial appearance, delayed bone age, increased adiposity
• Congenital GHD: size at birth is usually normal (in utero IGF-1 is not GH-dependent); micropenis may be present in boys
• Adults with GHD: reduced muscle mass (sarcopenia), increased central adiposity, osteoporosis, dyslipidemia, increased cardiovascular risk
• Causes: hypothalamic disease, disruption of portal blood supply, GHRHR mutations, somatotroph disease
• Can be isolated GHD or part of multiple pituitary hormone deficiency (MPHD) — Tietz Textbook of Laboratory Medicine, 7th ed.

• Growth retardation in children; bone age delayed

• Bone age less than chronologic age; decreased growth rate

• Bone age greater than chronologic age; initially accelerated growth but premature epiphyseal fusion leads to short final height

B. Chromosomal / Genetic Causes

• Short stature is a universal feature of non-mosaic Turner syndrome
• Loss of SHOX gene (short stature homeobox gene on Xp22.3) accounts for the growth deficit
• Other features: webbed neck, primary amenorrhea, broad chest, widely spaced nipples
• Treatment: GH (often combined with oxandrolone), then estrogen replacement

• SHOX mutations alone cause Leri-Weill dyschondrosteosis (forearm bowing, Madelung deformity)
• 5–15% of children with idiopathic short stature have a SHOX mutation (Xp23.33)
• Forearm anomalies become more evident during puberty
• FDA-approved indication for GH therapy

C. Chronic Systemic Disease

• Celiac disease, Crohn's disease, chronic renal failure, cystic fibrosis, cardiac failure, HIV, liver disease, chronic anemias
• Mechanism: secondary GH receptor resistance; proinflammatory cytokines block GH-mediated signal transduction
• These children show normal or elevated GH with low IGF-1

D. Nutritional / Psychosocial

• Nutritional short stature: caloric deprivation, uncontrolled diabetes, chronic renal failure — GH normal/elevated, IGF-1 low
• Psychosocial short stature: emotional/social deprivation → growth retardation, delayed speech, discordant hyperphagia, attenuated GH response. A nurturing environment restores growth. — Harrison's, 22nd ed.

E. Intrauterine Growth Restriction (IUGR) / Small for Gestational Age (SGA)

• Prenatal-onset growth failure

---

Bone Age Relationship to Causes

---

Diagnostic Approach

When to Evaluate

• Height >3 SD below mean, OR
• Growth rate has decelerated (height velocity declining)
• Clinical judgment integrated with auxologic data and family history
• Bone age by left wrist/hand radiograph (reliable after age 2 years)

Diagnostic Algorithm

Laboratory Workup

• CBC with differential (anemia, malignancy, inflammation)
• CRP/ESR (inflammation, infection)
• CMP — renal and liver function, calcium (malnutrition, renal/liver disorders)
• Urinalysis
• TSH, free T4 (hypothyroidism)
• TTG + IgA (celiac disease)
• Bone age radiograph

• IGF-1 and IGFBP-3 — proxy for GH axis; IGFBP-3 has higher specificity in children <10 years
  • Levels below the 5th percentile suggest GH deficiency
• Karyotype or SHOX gene testing — for Turner syndrome and SHOX mutations (especially girls with unexplained short stature)
• GH stimulation testing (provocative):
  • GH deficiency is best assessed by provocative tests (exercise, insulin-induced hypoglycemia, arginine, L-dopa, GHRH, macimorelin)
  • Normal response: GH peak >7 μg/L in children; a single subnormal test should be confirmed with a second test
  • Insulin Tolerance Test (ITT): gold standard; requires glucose <40 mg/dL; contraindicated with cardiac disease, seizure disorder
  • Arginine stimulation: 0.5 g/kg IV over 30 min; peak GH should be ≥5–7 ng/mL
  • Random GH measurements do NOT distinguish GHD from normal
• Pituitary MRI — for mass lesions or structural defects when GHD suspected
• Specific tests for cystic fibrosis, HIV, tuberculosis as clinically indicated

---

Growth Velocity Thresholds

---

Treatment

FDA-Approved Indications for Recombinant GH (Somatotropin)

1. Growth hormone deficiency — children and adults
2. Turner syndrome — GH (often + oxandrolone) to increase height
3. Chronic renal failure
4. Prader-Willi syndrome
5. Small for gestational age (SGA) — if not caught up by age 2–4 years
6. SHOX deficiency
7. Idiopathic short stature — height <2.25 SD below mean and unlikely to attain normal adult height

For Specific Conditions

• Hypothyroidism → L-thyroxine
• Cushing's syndrome → treatment of underlying cause
• Psychosocial short stature → nurturing environment restores growth
• Nutritional short stature → caloric rehabilitation
• Turner syndrome → GH + oxandrolone; estrogen replacement for pubertal induction
• Precocious puberty → GnRH analogs to slow bone maturation

---

Key Differentiating Points (Exam Summary)

---

• The Harriet Lane Handbook, 23rd ed. (Johns Hopkins)
• Harrison's Principles of Internal Medicine, 22nd ed.
• Tietz Textbook of Laboratory Medicine, 7th ed.
• Textbook of Family Medicine, 9th ed.
• Swanson's Family Medicine Review